By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Enterome, a privately held biomarker development firm, has raised €5 million ($6.6 million) in a series A round of private funding, it said Thursday.
Registering provides access to this and other free content.
Already have an account?Login Now.
Craig Venter's Human Longevity is deeply phenotyping individuals and capturing their genetic profiles to explore aging.
The San Francisco Business Times examines Verily's latest hires.
In Nature this week: comprehensive analysis of somatic mutations in breast cancer, and more.
A number of studies indicate that genes might influence political beliefs, Scientific American Mind reports.